Laurion Capital Management LP Aptinyx Inc. Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$2.86 - $4.33 $819,178 - $1.24 Million	-286,426 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$2.93 - $4.3 $839,228 - $1.23 Million	286,426 New	286,426 $991,000
Q4 2018 Feb 14, 2019	SELL	$16.15 - $28.93 $1.45 Million - $2.6 Million	-89,800 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$20.21 - $31.85 $3.24 Million - $5.1 Million	-160,200 Reduced 64.08%	89,800 $2.6 Million
Q2 2018 Aug 13, 2018	BUY	$19.83 - $24.17 $4.96 Million - $6.04 Million	250,000 New	250,000 $6.04 Million

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.